OraSure Technologies
OraSure Technologies Q4 Core Revenues up 10 Percent, Beat Estimates
The firm reported a $40 million decline in COVID-19-related revenues for the recently completed quarter compared to a year ago.
JP Morgan Healthcare Conference, Day 4: Standard BioTools, Geneoscopy, OraSure Technologies
Highlights from the fourth day included Geneoscopy's plans to increase access to its ColoSense colorectal cancer screening test through its partnership with Labcorp.
NowDx Countersues OraSure in Ongoing Legal Battle Over Point-of-Care Trade Secrets
Following OraSure's November 2024 lawsuit accusing NowDx of misappropriating trade secrets, NowDx has countersued OraSure over similar allegations.
In Brief This Week: Adaptive Biotechnologies, Qiagen, OraSure Technologies, Hologic, More
News items for the week of Jan. 6, 2025.
OraSure Technologies Q3 Core Revenues Fall 1 Percent
The firm also announced that it will exit its risk assessment drug testing business going forward.
Feb 23, 2022
OraSure Technologies Q4 Revenues Grow 1 Percent
Nov 3, 2021